Antibiotic resistance threats in patients with indwelling urinary catheters: bacterial spectrum, infection rates and the emergence of multidrug resistant and extensively drug resistant strains

  • Milan B. Potic Medical faculty University of Nis, Urology clinic, Clinical center Nis
  • Aleksandar Skakić ass.dr
  • Miodrag Djordjević
Keywords: Urinary tract infection, Indwelling urethral catheter, Health-care acquired infection, Multi-drug resistance, Extended drug resistance

Abstract


The extent of antimicrobial resistance has become a global threat and according to the World Health Organization latest reports on this issue 21stcentury could mark the end of the antibiotic era. Catheter-associated urinary tract infections are the leading cause of healthcare-associatedbacteremia and a major source of resistant gram-negativeorganisms. This paper focuses on antibacterial resistance of bacterial species isolated from the urine samples of bacteriuric patients. In this studywe examined urine cultures of patients with indwelling urethral catheters hospitalized for operative treatment and at higher risk for the emergence of hard to eradicate pathogens. We assessed underlying primary health conditions, comorbidities and infection risk factors in an attempt to relate them with rates of resistance. The results of susceptibility testing among positive urine isolates revealed high rates of resistanceto b-lactamase inhibitors, third-generation cephalosporins, fluoroquinolones andtrimethoprim-sulfamethoxazolealongside with combined resistance to third-generation cephalosporins, fluoroquinolones andaminoglycosides. Multi-drug resistant strains were isolated regardless of clinically apparent symptoms and signs of the infection with catheterization duration being the dominant factor in comparison to the severity of primary disease and comorbidities. Administration of empirical therapy failed to address resistance patterns of detected pathogens. The antimicrobial resistance crisis is aggravating and requires prompt and decisive response. Catheterization due to strictly defined indications, reduction of catheter presence duration and choice of therapeutic agent in accordance with susceptibilitytesting are currently best available strategies both for prevention and therapy.

 

Author Biography

Milan B. Potic, Medical faculty University of Nis, Urology clinic, Clinical center Nis

Specijalista urolog

Subspecijalista onkolog

References

Arnoldo L, Migliavacca R, Regattin L, Raglio A, Pagani L, Nucleo E et al. Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteria-ceae among catheterized inpatients in Italian long term care facilities. BMC Infect Dis 2013;13:124. [CrossRef] [PubMed]

Brennan BM, Coyle JR, Marchaim D, Pogue JM, Boehme M, Finks J et al. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan. Infect Contr Hosp Epidemiol 2014;35:342-9.[CrossRef] [PubMed]

Carolyn G, Craig AU, Rajender KA, Gretchen K, David AP. MD and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Pre-vention of Catheter-associated Urinary Tract Infections 2009. Available from: URL: https://www.cdc.gov/infectioncontrol/guidelines/cauti/

Čustović A, Zulčić-Nakić V, Aščerić M, Hadžić S. Surveillance of Intrahospital Infections at the Clinic for Gynaecology and Obstetrics. Bosnian Journal of Basic Medical Sciences. 2009;9(1):66-70. [CrossRef] [PubMed]

Darija K, Duška J, Miroslav P. Izolati multirezistentnih bakterija u Univerzitetskom kliničkom centru Republi-ke Srpske. Med Čas 2017;51(1):15-21.

European Centre for Disease Prevention and Control. Annual Epidemiological Report 2016 – Healthcare-associated infections acquired in intensive care units. Stockholm (SE): ECDC; 2016.

European Centre for Disease Prevention and Control. Summary of the latest data on antibiotic resistance in the European Union. Stockholm (SE): ECDC; 2016.

Fasugba O, Gardner A, Mitchell BG, Mnatzganian G. Ciprofloxacin Resistance in Community- and Hospital-Acquired Escherichia Coli Urinary Tract Infections: A Systematic Review and Meta-Analysis of Observational Studies. BMC Infect Dis 2015;15:545. [CrossRef] [PubMed]

G. Bonkat R, Pickard R, Bartoletti F, Bruyere SE, Geerlings F, Wagenlehner BW. Guidelines Associates: T. Cai, B. Kőves, A. Pilatz, B. Pradere, R. Veera-tterapillay (Last updated: March 2017) The European Association of Urology (EAU) Guidelines on Urological Infections. "cited 2017 June" Available from: URL: https://uroweb.org/guideline/urological-infections/

Givens CD, Wenzel RP. Catheter-associated urinary tract infections in surgical patients: A controlled study on the excess morbidity and costs. J Urol 1980; 124(5):646-8. [CrossRef] [PubMed]

Gupta K, Hooton TE, Naber KG, Wulit B, Colgan R, Miler LG et al. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the Euro-pean Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52(5)103-20. [CrossRef] [PubMed]

Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC et al. Diagnosis, prevention and treatment of catheter-associated urinary tract infec-tion in adults. 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50:625-63. [CrossRef] [PubMed]

Jacobsen SM, Stickler DJ, Mobley HL, Shirtiff ME. Complicated catheter-associated urinary tract infec-tions due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 2008;21:26-59. [CrossRef] [PubMed]

Lo E, Nicolle LE, Coffin SE, Gould C, Maragakis L, Meddings J et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals 2014 update. Infect Control Hosp Epidemiol 2014;35:464-79. [CrossRef] [PubMed]

Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA et al. Multistate point-pre-valence survey of healthcare-associated infections. N Engl J Med 2014;370:1198-208. [CrossRef] [PubMed]

Michael CA, Dominey-Howes D, Labbate M. The Antimicrobial Resistance Crisis: Causes, Consequen-ces, and Management. Front Pub Healt 2014;2:145. [CrossRef] [PubMed]

National Clinical Guideline Centre (UK). Infection: Prevention and Control of Healthcare-Associated In-fections in Primary and Community Care: Partial Update of NICE Clinical Guideline 2. London: Royal College of Physicians (UK); 2012.

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-85. [CrossRef] [PubMed]

Nicolle LE. Urinary catheter-associated infections. Infect Dis Clin North Am 2012; 6:13-28. [CrossRef] [PubMed]

Stark RP, Maki DG. Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med 1984;311:560-4. [CrossRef] [PubMed]

Stickler D, Sabbuba N. Disinfection and decontamina-tion: Principles, applications and related issues. Taylor and Francis Ltd 2007;18:415-55.

Ventola CL. The Antibiotic Resistance Crisis: Part 1: Causes and Threats. Pharm and Ther 2015; 40(4): 277-83. [PubMed]

Wagenlehner F, Tandogdu Z, Bartoletti R, Cai T, Cek M, Kulchavenya E et al. The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections. Pathog 2016;5:223-37. [CrossRef] [PubMed]

Zvonimir B, Andrea BE, Elmica B, Vinko Z, Vanja K, Merica C. Urinary tract infections in South Croatia: aetiology and antimicrobial resistance. Int J Antimicrob Ag 2003;22: 61-4. [CrossRef]

Published
2020/12/29
Section
Original article